Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Following the Central Dogma: A Review of Fluoroquinolone Resistance Mechanisms in Aquatic Pathogenic Bacteria

4 affiliations
  1. 1College of Food Science and Technology, Shanghai Ocean University, 999# Hu Cheng Huan Road, Shanghai 201306, China
  2. 2International Research Center for Food and Health, Shanghai Ocean University, 999# Hu Cheng Huan Road, Shanghai 201306, China
  3. 3Laboratory of Quality & Safety Risk Assessment for Aquatic Products on Storage and Preservation (Shanghai), Ministry of Agriculture and Rural Affairs, 999# Hu Cheng Huan Road, Shanghai 201306, China
  4. 4Shanghai Engineering Research Center of Aquatic-Product Processing & Preservation, 999# Hu Cheng Huan Road, Shanghai 201306, China

Abstract

Fluoroquinolone resistance in aquatic bacterial pathogens is a growing concern in aquaculture worldwide. Multidrug-resistant isolates are increasingly reported across major farming regions, and the potential transmission of resistance genes to humans through the food chain and environmental exposure has attracted attention beyond aquaculture. Most existing reviews discuss individual resistance mechanisms, such as target-site mutations, plasmid-mediated quinolone resistance (PMQR), efflux pumps, and altered membrane permeability, as discrete topics, with limited consideration of their interrelationships. This review takes a different approach. Using the central dogma of molecular biology as an organizing framework, it organizes fluoroquinolone resistance into four interconnected levels: gene, transcription, protein, and phenotype. Gene-level resistance involves point mutations in the quinolone resistance-determining region (QRDR) and the acquisition of PMQR genes. Transcriptional responses include coordinated upregulation of efflux pumps and downregulation of porins, which together reduce intracellular drug accumulation. Protein-level mechanisms include altered drug targets, target protection by Qnr proteins, drug efflux, and enzymatic modification of the drug. At the phenotypic level, PMQR-mediated low-level resistance provides a survival window during which subsequent QRDR mutations accumulate, whereas efflux pump overexpression confers higher-level resistance. Biofilm formation and metabolic reprogramming further stabilize the resistance phenotype at the population level. This framework highlights how resistance mechanisms interact across different molecular and cellular levels, rather than functioning independently or following a strictly linear sequence. Key gaps remain in understanding the regulatory roles of non-coding RNAs, the structural biology of PMQR proteins, and the use of multi-omics approaches to clarify regulation across these levels. Further research is needed to address these gaps.

Related

  1. Relative Contributions of Quinolone Resistance-Determining Region Mutations and Efflux Pump-Associated Mechanisms to Fluoroquinolone Resistance in Staphylococcus aureus Clinical Isolates and Their Associations with Virulence Gene Profiles.
    Sohyeong Kim, Heechul Park, Minju Jung +8
    Antibiotics (Basel, Switzerland)Peer-reviewedCC BYFull textInfectious diseaseEurope PMC
  2. Beyond the patient: Inanimate objects as reservoirs for potential pathogenic bacteria and antimicrobial resistance patterns in hospital wards, a cross-sectional study from Goba Referral Hospital.
    Jemal Esmael, Mohammedaman Mama, Awel Kedir +1
    BMC microbiologyPeer-reviewedCC BY-NC-NDFull textInfectious diseaseEurope PMCPMC
  3. Peritoneal Dialysis-Associated Peritonitis due to Pasteurella multocida: A Rare Case of Stray-Animal Exposure and Fluoroquinolone Resistance
    Melih Tarık Özdemir, Neslihan Arıcı, Elif Gülcan Şenol +2
    Infectious diseases & clinical microbiologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
    Lunmin Bao, Haibing Dai, Daoming Wang +1
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  5. Cryo-EM reveals the quaternary architecture of TenpIN type III toxin-antitoxin RNP complex common to pathogenic bacteria
    Kavyashree Nadig, Surekha Padmanaban, Salik Noor +4
    PLOS PathogensPeer-reviewedCC BYFull textMolecular biology & gene regulationMicrobiologyPLOSEurope PMC
BibTeX
@article{zhu2026following,
  title = {{Following the Central Dogma: A Review of Fluoroquinolone Resistance Mechanisms in Aquatic Pathogenic Bacteria}},
  author = {Lei Zhu and Cangle Dai and Mengcao Wang and Xinyi Zhu and Jing Ma and Yihan Zhang and Yong Zhao and Huan Li and Zhaohuan Zhang},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = oct,
  doi = {10.3390/ijms27219603},
  url = {https://www.mdpi.com/1422-0067/27/21/9603},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Following the Central Dogma: A Review of Fluoroquinolone Resistance Mechanisms in Aquatic Pathogenic Bacteria
AU  - Lei Zhu
AU  - Cangle Dai
AU  - Mengcao Wang
AU  - Xinyi Zhu
AU  - Jing Ma
AU  - Yihan Zhang
AU  - Yong Zhao
AU  - Huan Li
AU  - Zhaohuan Zhang
PY  - 2026
DA  - 2026/10/27
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27219603
UR  - https://www.mdpi.com/1422-0067/27/21/9603
AB  - Fluoroquinolone resistance in aquatic bacterial pathogens is a growing concern in aquaculture worldwide. Multidrug-resistant isolates are increasingly reported across major farming regions, and the potential transmission of resistance genes to humans through the food chain and environmental exposure has attracted attention beyond aquaculture. Most existing reviews discuss individual resistance mechanisms, such as target-site mutations, plasmid-mediated quinolone resistance (PMQR), efflux pumps, and altered membrane permeability, as discrete topics, with limited consideration of their interrelationships. This review takes a different approach. Using the central dogma of molecular biology as an organizing framework, it organizes fluoroquinolone resistance into four interconnected levels: gene, transcription, protein, and phenotype. Gene-level resistance involves point mutations in the quinolone resistance-determining region (QRDR) and the acquisition of PMQR genes. Transcriptional responses include coordinated upregulation of efflux pumps and downregulation of porins, which together reduce intracellular drug accumulation. Protein-level mechanisms include altered drug targets, target protection by Qnr proteins, drug efflux, and enzymatic modification of the drug. At the phenotypic level, PMQR-mediated low-level resistance provides a survival window during which subsequent QRDR mutations accumulate, whereas efflux pump overexpression confers higher-level resistance. Biofilm formation and metabolic reprogramming further stabilize the resistance phenotype at the population level. This framework highlights how resistance mechanisms interact across different molecular and cellular levels, rather than functioning independently or following a strictly linear sequence. Key gaps remain in understanding the regulatory roles of non-coding RNAs, the structural biology of PMQR proteins, and the use of multi-omics approaches to clarify regulation across these levels. Further research is needed to address these gaps.
SN  - 1422-0067
ER  -